Form 4: Amgen Director Mary E. Klotman Reports Acquisition of Common Stock

Director Mary E. Klotman reports acquiring 719 shares of Amgen common stock on May 31, 2024, through vested Restricted Stock Units (RSUs).

Summary

• On May 31, 2024, Mary E. Klotman, a director of Amgen Inc., reported acquiring 719 shares of Amgen common stock.
• The acquisition was a result of the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are payable in shares of Amgen's common stock on a one-to-one basis.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction (RSU vesting) and doesn't necessarily indicate a strong positive or negative outlook for the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Director share acquisitions are common and are viewed as a sign of confidence in the company's prospects.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals director confidence.

Key Dates